Teva, Medicis Strike Deal On Acne Drug Solodyn
Generic-drug maker Teva Pharmaceutical Industries Ltd. will stop shipping a popular anti-acne medication for the time being under a newly announced patent agreement with skin health specialist Medicis Pharmaceutical Corp., the...To view the full article, register now.
Already a subscriber? Click here to view full article